Category: Latest News
-
INmune Bio Shares Surge as Prostate Cancer Trial Achieves Key Goals
INmune Bio Inc. (NASDAQ:INMB) saw its stock jump 28% on Monday after announcing that its Phase I/II trial evaluating INKmune™ in patients with metastatic castration-resistant prostate cancer (mCRPC) successfully met both its primary and secondary endpoints. With enrollment now closed, the company is preparing for the next phase of development. The CaRe PC trial, conducted…
-
Praxis Precision Medicines Shares Surge on Promising Epilepsy Drug Data
Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) soared 27% on Monday after the company released encouraging top-line results from its Phase 2 RADIANT trial, which evaluated vormatrigine in individuals with focal onset seizures. According to the clinical-stage biotech firm, patients treated with vormatrigine over an eight-week period experienced a 56.3% median reduction in seizure frequency.…
-
U.S. stocks climb on rising rate cut hopes; earnings season heats up
U.S. stocks rebounded Monday, reversing Friday’s payroll-driven sell-off as investors grew optimistic about potential interest rate cuts. At 09:35 ET, the Dow Jones Industrial Average rose 268 points (0.6%), the S&P 500 gained 45 points (0.7%), and the NASDAQ Composite added 210 points (1%). Friday’s sharp decline saw the S&P 500 record its worst day…
-
Morgan Stanley’s recent survey reveals Gen Z’s waning enthusiasm for Tesla
Tesla’s allure among younger consumers seems to be diminishing, based on Morgan Stanley’s latest survey of interns. Only 5% of participants chose Tesla (NASDAQ:TSLA) as their “most desirable car brand,” a significant drop from 11% last year and far below its peak of 30% in 2021. This survey, which polled roughly 530 North American interns,…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Set for Bounce Back as Investors Hunt Bargains After Sharp Sell-Off
U.S. stock futures are indicating gains for Monday’s open, as markets aim to recover from steep declines experienced over the past two trading days. Following a significant pullback that pushed the Nasdaq and S&P 500 far below their recent all-time highs, bargain hunters seem ready to jump back in, snapping up shares at reduced prices.…
-
SiriusPoint beats Q2 expectations with 89.5% Core combined ratio
On Monday, SiriusPoint Ltd. (NYSE:SPNT) reported second-quarter earnings that surpassed analyst expectations, driven by improved underwriting results and robust premium growth. Following the announcement, the insurance and reinsurance provider’s shares rose 0.46% in after-hours trading. The company posted adjusted earnings per share of $0.66 for the quarter, beating the analyst consensus of $0.59. Revenue reached…
-
Loews Corp. reports 6% rise in Q2 net income, shares edge higher
On Monday, Loews Corporation (NYSE:L) announced second-quarter net income of $391 million, or $1.87 per share, marking a 6% increase from $369 million, or $1.67 per share, in the same quarter last year. The diversified holding company’s revenue rose to $4.56 billion for the period. Following the earnings release, Loews’ shares edged up 1.26% in…
-
CNA Financial beats Q2 estimates with $1.23 EPS, shares dip slightly
CNA Financial Corporation (NYSE:CNA) reported second-quarter 2025 core income of $335 million, or $1.23 per share, surpassing analyst expectations of $0.98 per share. Despite the strong results, shares slipped 0.62% in after-hours trading following the announcement. The insurance company’s core income rose 3% from $326 million, or $1.19 per share, in the same quarter last…
-
Energizer shares jump over 10% as battery maker exceeds earnings expectations
Energizer Holdings, Inc. (NYSE:ENR) reported fiscal third-quarter results on Monday that significantly surpassed analyst forecasts, powered by production tax credits and operational efficiencies. The company’s shares surged 10.61% in pre-market trading following the announcement. The battery and auto care products manufacturer posted adjusted earnings per share of $1.13 for the quarter ended June 30, 2025,…
-
IDEXX Laboratories shares climb over 3% as Q2 earnings beat estimates
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter earnings that surpassed analyst expectations on Monday, boosted by strong instrument placements and solid growth in recurring diagnostic revenue. Following the announcement, the company’s shares rose 3.63% in pre-market trading. The pet healthcare innovator posted adjusted earnings of $3.63 per share, beating the consensus estimate of $3.29. Revenue increased 11%…